311 related articles for article (PubMed ID: 12508245)
21. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
22. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.
Nanri T; Uike N; Kawakita T; Iwanaga E; Mitsuya H; Asou N
Genes Chromosomes Cancer; 2010 Mar; 49(3):237-41. PubMed ID: 19953636
[TBL] [Abstract][Full Text] [Related]
23. Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha.
Hernandez R; Teruel T; Lorenzo M
Biochem J; 2003 Jun; 372(Pt 2):617-24. PubMed ID: 12641495
[TBL] [Abstract][Full Text] [Related]
24. Functional interaction of transcriptional coactivator ASC-2 and C/EBPalpha in granulocyte differentiation of HL-60 promyelocytic cell.
Hong S; Lee MY; Cheong J
Biochem Biophys Res Commun; 2001 Apr; 282(5):1257-62. PubMed ID: 11302752
[TBL] [Abstract][Full Text] [Related]
25. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
26. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].
Zhao JM; Wang HW; Xu ZF; Zhu L; Bai B; Ge XY
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):299-302. PubMed ID: 15949295
[TBL] [Abstract][Full Text] [Related]
27. C/EBPalpha in leukemogenesis: a matter of being in the right place with the right signals.
Castilla LH
Cancer Cell; 2008 Apr; 13(4):289-91. PubMed ID: 18394549
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
29. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
Schuster MB; Porse BT
Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
[TBL] [Abstract][Full Text] [Related]
30. Involvement of CCAAT/enhancer-binding protein alpha in haptoglobin gene expression by all-trans-retinoic acid.
Lee IH; Lee JH; Lee MJ; Lee SY; Kim IS
Biochem Biophys Res Commun; 2002 Jun; 294(5):956-61. PubMed ID: 12074569
[TBL] [Abstract][Full Text] [Related]
31. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
Shimokawa T; Nunomura S; Fujisawa D; Ra C
Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
[TBL] [Abstract][Full Text] [Related]
32. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
[TBL] [Abstract][Full Text] [Related]
33. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis.
Tang QQ; Zhang JW; Daniel Lane M
Biochem Biophys Res Commun; 2004 May; 318(1):213-8. PubMed ID: 15110775
[TBL] [Abstract][Full Text] [Related]
34. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
[TBL] [Abstract][Full Text] [Related]
35. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.
Wang QF; Cleaves R; Kummalue T; Nerlov C; Friedman AD
Oncogene; 2003 May; 22(17):2548-57. PubMed ID: 12730669
[TBL] [Abstract][Full Text] [Related]
37. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.
Kaeferstein A; Krug U; Tiesmeier J; Aivado M; Faulhaber M; Stadler M; Krauter J; Germing U; Hofmann WK; Koeffler HP; Ganser A; Verbeek W
Leukemia; 2003 Feb; 17(2):343-9. PubMed ID: 12592334
[TBL] [Abstract][Full Text] [Related]
38. Differentiation or leukemia: is C/EBPalpha the answer?
Hiebert S
Nat Med; 2001 Apr; 7(4):407-8. PubMed ID: 11283659
[No Abstract] [Full Text] [Related]
39. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
Snaddon J; Smith ML; Neat M; Cambal-Parrales M; Dixon-McIver A; Arch R; Amess JA; Rohatiner AZ; Lister TA; Fitzgibbon J
Genes Chromosomes Cancer; 2003 May; 37(1):72-8. PubMed ID: 12661007
[TBL] [Abstract][Full Text] [Related]
40. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
